US Stock Market Move | Medicare Advantage plan ratings improve significantly, Humana (HUM.US) surges nearly 12%.
On Friday, Humana (HUM.US) shares surged nearly 18% in early trading, and as of press time, they were up nearly 12%, at $432.80.
On Friday, Humana (HUM.US) shares surged nearly 18% at one point in early trading, and as of press time, were up nearly 12% at $433.07. On the news front, Humana disclosed that 95% of its relevant enrollees are in plans rated four stars or above. Based on the final 2027 Medicare Advantage star ratings data, Humana expects its average star rating revenue per enrollee per month to reach $160 by 2027. The company said this performance has exceeded its "top quartile" target, which is 10% above the peer average. Humana reiterated its fiscal 2026 adjusted earnings per share guidance of at least $9.
Related Articles
US Stock Market Move | U.S. clinical-stage biopharmaceutical company Retension Pharmaceuticals (RTSN.US) debuted on the U.S. stock market, with its share price falling more than 10% after the opening bell.
US Stock Market Move | Trex Bio (TRXB.US) debuts on the U.S. stock market, falling more than 1.3% after the open.
US Stock Market Move | Included in the Nasdaq 100 Index, Moderna (MRNA.US) rises 7%.
US Stock Market Move | U.S. clinical-stage biopharmaceutical company Retension Pharmaceuticals (RTSN.US) debuted on the U.S. stock market, with its share price falling more than 10% after the opening bell.
US Stock Market Move | Trex Bio (TRXB.US) debuts on the U.S. stock market, falling more than 1.3% after the open.
US Stock Market Move | Included in the Nasdaq 100 Index, Moderna (MRNA.US) rises 7%.
